HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Gregory M Lanza Selected Research

fumagillin

11/2012Suppression of inflammation in a mouse model of rheumatoid arthritis using targeted lipase-labile fumagillin prodrug nanoparticles.
9/2010Synergistic effect of antiangiogenic nanotherapy combined with methotrexate in the treatment of experimental inflammatory arthritis.
9/2009Alphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in mice.
9/2008Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis.
8/2008Minute dosages of alpha(nu)beta3-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbits.
9/2006Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Gregory M Lanza Research Topics

Disease

21Neoplasms (Cancer)
08/2015 - 09/2003
8Atherosclerosis
01/2015 - 11/2003
8Thrombosis (Thrombus)
01/2012 - 08/2003
7Inflammation
07/2014 - 01/2008
6Atherosclerotic Plaque (Atheroma)
01/2015 - 12/2004
4Pathologic Constriction (Stenosis)
01/2012 - 12/2004
4Stroke (Strokes)
09/2011 - 08/2003
3Cardiovascular Diseases (Cardiovascular Disease)
01/2015 - 01/2007
3Arthritis (Polyarthritis)
11/2012 - 09/2009
3Rupture
02/2012 - 12/2004
3Melanoma (Melanoma, Malignant)
08/2008 - 03/2005
2Ischemia
01/2014 - 01/2004
2Breast Neoplasms (Breast Cancer)
01/2013 - 08/2010
2Body Weight (Weight, Body)
11/2012 - 08/2010
2Nephrogenic Fibrosing Dermopathy
03/2011 - 07/2008
2Vascular System Injuries
05/2008 - 03/2004
1Multiple Myeloma
06/2015
1Edema
01/2015
1Muscular Dystrophies (Muscular Dystrophy)
05/2014
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
05/2014
1Hemolysis
04/2014
1Hyperoxia
07/2013
1Rheumatoid Arthritis
11/2012
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2012
1Kidney Diseases (Kidney Disease)
03/2011
1Vascular Diseases (Vascular Disease)
12/2009
1Myocardial Infarction
06/2009
1Metrorrhagia (Spotting)
01/2009
1Adenocarcinoma
08/2008
1Neointima
05/2008
1X-Linked Genetic Diseases
08/2007
1Hypertension (High Blood Pressure)
05/2004
1Marfan Syndrome (Marfan's Syndrome)
05/2004
1Pathologic Processes
05/2004
1Hematoma
01/2004
1Hemorrhage
01/2004
1False Aneurysm (Pseudoaneurysm)
01/2004

Drug/Important Bio-Agent (IBA)

12FibrinIBA
04/2012 - 08/2003
11Contrast MediaIBA
01/2015 - 02/2006
6fumagillinIBA
11/2012 - 09/2006
5Biological Markers (Surrogate Marker)IBA
01/2015 - 09/2003
3perflubron (L 1913)FDA Link
08/2015 - 06/2006
3Lipase (Acid Lipase)FDA Link
06/2015 - 11/2012
3LigandsIBA
11/2013 - 08/2008
3GadoliniumIBA
03/2011 - 07/2008
3glucuronyl glucosamine glycan sulfate (Vessel)IBA
05/2010 - 12/2004
3CholesterolIBA
12/2008 - 11/2003
2FluorineIBA
01/2015 - 01/2008
2Sirolimus (Rapamycin)FDA Link
05/2014 - 05/2008
2Apolipoproteins E (ApoE)IBA
11/2013 - 01/2013
2gadolinium diethylene-triamine-pentaacetic acid-bis-oleateIBA
08/2013 - 08/2003
2Melitten (Melittin)IBA
12/2011 - 09/2009
2RhodaminesIBA
06/2011 - 03/2011
2Thromboplastin (Tissue Factor)IBA
02/2006 - 03/2004
1ProdrugsIBA
06/2015
1AntigensIBA
01/2015
1Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2014
1Adrenal Cortex Hormones (Corticosteroids)IBA
05/2014
1Complement System Proteins (Complement)IBA
04/2014
1taxaneIBA
01/2014
1Paclitaxel (Taxol)FDA LinkGeneric
01/2014
1gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA
08/2013
1OxygenIBA
07/2013
1arsenic trioxide (Trisenox)FDA Link
01/2012
1Aligeron (AS 2)IBA
01/2012
1Epidermal Growth Factor Receptor (EGF Receptor)IBA
01/2012
1CopperIBA
06/2011
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
06/2011
1Methotrexate (Mexate)FDA LinkGeneric
09/2010
1Insulin (Novolin)FDA Link
08/2010
1LeptinIBA
08/2010
1benfluorex (S 780)IBA
08/2010
1Molecular Probes (Molecular Probe)IBA
07/2010
1tranilast (N 5')IBA
05/2010
1Gadolinium DTPA (Magnevist)FDA Link
05/2010
1ferric oxide (iron oxide)IBA
12/2009
1harpin (messenger)IBA
11/2009
1CytokinesIBA
11/2009
1Proteoglycans (Proteoglycan)IBA
09/2009
1PeptidesIBA
09/2009
1Angiogenesis InhibitorsIBA
09/2009
1ManganeseIBA
06/2009
1Gold Colloid (Colloidal Gold)IBA
01/2009
1atorvastatin (Lipitor)FDA Link
09/2008
1DystrophinIBA
08/2007
1EpitopesIBA
06/2007
1IntegrinsIBA
06/2007
1Integrin beta3 (GPIIIa)IBA
09/2006
1CollagenIBA
05/2004
1ElastinIBA
05/2004
1Glycoproteins (Glycoprotein)IBA
03/2004
1AntibodiesIBA
08/2003

Therapy/Procedure

3Drug Therapy (Chemotherapy)
01/2014 - 01/2009
2Heterologous Transplantation (Xenotransplantation)
08/2010 - 03/2005
1Ligation
01/2014
1Stents
01/2012
1Angioplasty (Angioplasty, Transluminal)
01/2012
1Therapeutics
09/2009
1Microbubbles
06/2006
1Blood Transfusion (Blood Transfusions)
01/2004